Michelow Pam, Hartman Ingrid, Schulze Doreen, Lamla-Hillie Stella, Williams Sophie, Levin Simon, Firnhaber Cynthia
Department of Anatomical Pathology, Cytopathology Unit, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa.
Cytojournal. 2010 Jun 12;7:8. doi: 10.4103/1742-6413.64376.
South Africa has very high rates of both HIV infection and cervical pathology. The management of ASC-H is colposcopy and directed biopsy, but with so many women diagnosed with HSIL and a dearth of colposcopy centres in South Africa, women with cytologic diagnosis of ASC-H may not be prioritized for colposcopy. The aim of this study was to determine if HIV-positive women with a cytologic diagnosis of ASC-H should undergo immediate colposcopy or whether colposcopy can be delayed, within the context of an underfunded health care setting with so many competing health needs.
A computer database search was performed from the archives of an NGO-administered clinic that offers comprehensive HIV care. All women with a cytologic diagnosis of ASC-H on cervical smears from September 2005 until August 2009 were identified. Histologic follow up was sought in all patients.
A total of 2111 cervical smears were performed and 41 diagnosed as ASC-H (1.94%). No histologic follow up data was available in 15 cases. Follow up histologic results were as follows: three negative (11.5%), five koilocytosis and/ or CIN1 (19.2%), ten CIN2 (38.5%) and eight CIN3 (30.8%). There were no cases of invasive carcinoma on follow up.
The current appropriate management of HIV-positive women in low-resource settings with a diagnosis of ASC-H on cervical smear is colposcopy, despite the costs involved. In the future and if cost-effective in developing nations, use of novel markers may help select which HIV-positive women can be managed conservatively and which ones referred for more active treatment. More research in this regard is warranted.
南非的艾滋病毒感染率和宫颈病变率都非常高。非典型鳞状细胞不排除高度病变(ASC-H)的管理方法是阴道镜检查和定向活检,但由于南非有如此多被诊断为高级别鳞状上皮内病变(HSIL)的女性,且阴道镜检查中心匮乏,因此细胞学诊断为ASC-H的女性可能无法优先接受阴道镜检查。本研究的目的是确定在医疗保健资金不足且存在众多相互竞争的健康需求的情况下,细胞学诊断为ASC-H的艾滋病毒阳性女性是否应立即接受阴道镜检查,或者阴道镜检查是否可以推迟。
从一个提供全面艾滋病毒护理的非政府组织管理的诊所档案中进行计算机数据库搜索。确定了2005年9月至2009年8月期间宫颈涂片细胞学诊断为ASC-H的所有女性。对所有患者进行了组织学随访。
共进行了2111次宫颈涂片检查,41例被诊断为ASC-H(1.94%)。15例没有组织学随访数据。随访组织学结果如下:3例阴性(11.5%),5例挖空细胞和/或宫颈上皮内瘤变1级(CIN1,19.2%),10例CIN2(38.5%),8例CIN3(30.8%)。随访中没有浸润癌病例。
在资源匮乏地区,目前对宫颈涂片诊断为ASC-H的艾滋病毒阳性女性的适当管理方法是阴道镜检查,尽管费用较高。未来,如果在发展中国家具有成本效益,使用新型标志物可能有助于选择哪些艾滋病毒阳性女性可以保守治疗,哪些需要转诊接受更积极的治疗。在这方面需要进行更多的研究。